OX513A has been successfully evaluated at a number of laboratories including at the Institut Pasteur in Paris and at the WHO Collaborating Centre for Vectors at the Institute for Medical Research (IMR) in Malaysia. OX513A has demonstrated stable performance over 60 generations.
The key indicator of success is competitiveness against local males to achieve mating with wild females. Mating competitiveness trials by the IMR in a purpose-built field house showed that OX513A males competed effectively with wild-type local males for matings with local wild-type females, a critical indicator of success in the field. The IMR also conducted a series of binomial studies on parameters such as longevity, development times and egg-laying, none of which showed any significant difference between the OX513A and the wild-type strain.